The Cancer Genetics market is a subset of the Genomics market, focusing on the study of genetic mutations associated with cancer. This includes the identification of genetic markers that can be used to diagnose, monitor, and treat cancer. It also includes the development of targeted therapies and personalized medicine. Cancer Genetics research is conducted through a variety of methods, such as sequencing, bioinformatics, and gene expression analysis. The Cancer Genetics market is driven by the increasing prevalence of cancer, advances in technology, and the growing demand for personalized medicine. Additionally, the increasing availability of genomic data and the development of new technologies are expected to drive the market in the future. Some companies in the Cancer Genetics market include Illumina, Thermo Fisher Scientific, BGI, QIAGEN, and Agilent Technologies. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
